Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC.

Virol J. 2013 Dec 5;10:349. doi: 10.1186/1743-422X-10-349.

2.

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.

López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2309. doi: 10.1371/journal.pntd.0002309. Print 2013.

3.

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.

Warimwe GM, Gesharisha J, Carr BV, Otieno S, Otingah K, Wright D, Charleston B, Okoth E, Elena LG, Lorenzo G, Ayman el-B, Alharbi NK, Al-dubaib MA, Brun A, Gilbert SC, Nene V, Hill AV.

Sci Rep. 2016 Feb 5;6:20617. doi: 10.1038/srep20617.

4.

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.

Busquets N, Lorenzo G, López-Gil E, Rivas R, Solanes D, Galindo-Cardiel I, Abad FX, Rodríguez F, Bensaid A, Warimwe G, Gilbert SC, Domingo M, Brun A.

Antiviral Res. 2014 Aug;108:165-72. doi: 10.1016/j.antiviral.2014.05.020. Epub 2014 Jun 14.

PMID:
24933081
5.

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ.

Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24.

PMID:
22449427
6.

Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

Morrill JC, Laughlin RC, Lokugamage N, Pugh R, Sbrana E, Weise WJ, Adams LG, Makino S, Peters CJ.

Vaccine. 2013 Jan 7;31(3):559-65. doi: 10.1016/j.vaccine.2012.10.118. Epub 2012 Nov 12.

7.

Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.

Ikegami T.

Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2. Review.

8.

Development of a novel, single-cycle replicable rift valley Fever vaccine.

Murakami S, Terasaki K, Ramirez SI, Morrill JC, Makino S.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2746. doi: 10.1371/journal.pntd.0002746. eCollection 2014 Mar.

9.

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.

von Teichman B, Engelbrecht A, Zulu G, Dungu B, Pardini A, Bouloy M.

Vaccine. 2011 Aug 5;29(34):5771-7. doi: 10.1016/j.vaccine.2011.05.055. Epub 2011 Jun 12.

PMID:
21664400
10.

Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.

Papin JF, Verardi PH, Jones LA, Monge-Navarro F, Brault AC, Holbrook MR, Worthy MN, Freiberg AN, Yilma TD.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14926-31. doi: 10.1073/pnas.1112149108. Epub 2011 Aug 23.

11.

Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

Morrill JC, Laughlin RC, Lokugamage N, Wu J, Pugh R, Kanani P, Adams LG, Makino S, Peters CJ.

Vaccine. 2013 Oct 9;31(43):4988-94. doi: 10.1016/j.vaccine.2013.08.003. Epub 2013 Aug 27.

12.

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle.

Dulal P, Wright D, Ashfield R, Hill AV, Charleston B, Warimwe GM.

Vaccine. 2016 Apr 29;34(20):2296-8. doi: 10.1016/j.vaccine.2016.03.061. Epub 2016 Mar 25.

13.

Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.

Soi RK, Rurangirwa FR, McGuire TC, Rwambo PM, DeMartini JC, Crawford TB.

Clin Vaccine Immunol. 2010 Dec;17(12):1842-9. doi: 10.1128/CVI.00220-10. Epub 2010 Sep 28.

14.

Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.

Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albariño CG.

J Virol. 2012 Apr;86(8):4204-12. doi: 10.1128/JVI.07104-11. Epub 2012 Feb 15.

15.

A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.

Holman DH, Penn-Nicholson A, Wang D, Woraratanadharm J, Harr MK, Luo M, Maher EM, Holbrook MR, Dong JY.

Clin Vaccine Immunol. 2009 Nov;16(11):1624-32. doi: 10.1128/CVI.00182-09. Epub 2009 Sep 23.

16.

A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.

Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I, Young A, Richt JA.

Vector Borne Zoonotic Dis. 2014 Oct;14(10):746-56. doi: 10.1089/vbz.2014.1650.

17.

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN.

J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.

18.

[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].

Wang QH, Wang XJ, Hu S, Ge JY, Bu ZG.

Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81. Chinese.

PMID:
17944371
19.

Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels.

Daouam S, Ghzal F, Naouli Y, Tadlaoui KO, Ennaji MM, Oura C, El Harrak M.

BMC Vet Res. 2016 Jul 26;12(1):154. doi: 10.1186/s12917-016-0775-8.

20.

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

Bhardwaj N, Heise MT, Ross TM.

PLoS Negl Trop Dis. 2010 Jun 22;4(6):e725. doi: 10.1371/journal.pntd.0000725.

Supplemental Content

Support Center